Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE(PATH-STROKE)

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,020

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Ischemic StrokeAntiplatelet Drug
Interventions
DRUG

Precision Antiplatelet Therapy Trial Group

Use SPCM method to detect platelet aggregation function in patients, adjust antiplatelet drugs based on the test results, and receive precise antiplatelet treatment for 12 months. Non resistant patients with aspirin will continue to receive aspirin 100mg qd; Patients with aspirin resistance were given clopidogrel 75mg qd; Clopidogrel resistant patients were given ticagrelor 90mg bid.

DRUG

Traditional Antiplatelet Therapy Control Group

No adjustment of antiplatelet medication is required, and routine treatment with aspirin 100mg qd is given for 12 months.

Trial Locations (1)

610072

RECRUITING

Sichuan Provincial People's Hospital, Chengdu

All Listed Sponsors
lead

Sichuan Provincial People's Hospital

OTHER